Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus.
Anders A BengtssonHelena TydenChristian LoodPublished in: Arthritis research & therapy (2020)
This novel FcγRIIA-IC assay can detect levels of circulating ICs in patients with SLE. Analyzing IC levels may facilitate monitoring of disease activity, as well as identify patients at risk of lupus nephritis, allowing for early preventive interventions.